Finance

Beta
Ask
Lists
RX:CVE
Biosyent Inc
CA$13.95
0.00%
(0.00) 1D
Jun 19, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for RX...
Open
CA$14.02
High
CA$14.02
Low
CA$13.95
Mkt. cap
162.18M
Avg. vol.
8.80K
Volume
10.60K
Dividend
1.58%
Quarterly dividend
CA$0.05
Ex-dividend date
May 29, 2026
P/E ratio
17.79
52-wk high
CA$15.80
52-wk low
CA$10.65
EPS
CA$0.78
Beta
0.29
Shares outstanding
11.44M
No. of employees
0
Open
CA$14.02
High
CA$14.02
Low
CA$13.95
Mkt. cap
162.18M
Avg. vol.
8.80K
Volume
10.60K
Dividend
1.58%
Quarterly dividend
CA$0.05
Ex-dividend date
May 29, 2026
P/E ratio
17.79
52-wk high
CA$15.80
52-wk low
CA$10.65
EPS
CA$0.78
Beta
0.29
Shares outstanding
11.44M
No. of employees
0
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to RX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for RX in the last 3 months.
Highest
Current CA$13.95
CA$18.00 (+29.03%)
Average
CA$18.00 (+29.03%)
Lowest
CA$18.00 (+29.03%)
News stories
From sources across the web
About Biosyent Inc
CEO-
Employees0
Founded1947
HeadquartersMississauga, Ontario, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.18M
12.22M
9.67M
13.91M
Cost of goods sold
2.27M
2.95M
2.23M
3.74M
Cost of revenue
2.27M
2.95M
2.23M
3.74M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.37M
5.84M
5.22M
6.75M
Operating expense
5.37M
5.84M
5.22M
6.75M
Total operating expenses
7.63M
8.79M
7.45M
10.49M
Operating income
2.55M
3.43M
2.22M
3.42M
Other non operating income
-
-
-
-
EBT including unusual items
2.75M
3.65M
2.48M
3.29M
EBT excluding unusual items
2.75M
3.65M
2.48M
3.56M
Income tax expense
727.64K
967.10K
486.60K
940.48K
Effective tax rate
26.50%
26.50%
19.63%
28.63%
Other operating expenses
-
-
-
-
Net income
2.02M
2.68M
1.99M
2.34M
Net profit margin
19.83%
21.95%
20.59%
16.86%
Earnings per share
-
-
-
-
Interest and investment income
210.93K
231.39K
187.77K
166.79K
Interest expense
-12.63K
-12.14K
-11.48K
-31.62K
Net interest expenses
198.30K
219.25K
176.29K
135.18K
Depreciation and amortization charges
-
-
-
-
EBITDA
2.67M
3.65M
2.41M
3.86M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more